Fiche centre
Investigational Site Number : 7920003
Istanbul — Turkey (Türkiye)
Essais liés3clinical trials
VilleIstanbullocalisation
PaysTurkey (Türkiye)localisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04458051
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Alemtuzumab GZ402673 | SEP | Phase 3 | NCT03368664 | LemKids — A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT | TERMINATED |
| Tolebrutinib | SEP | Phase 3 | NCT06372145 | A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. | ACTIVE_NOT_RECRUITING |
| Tolebrutinib | SEP | Phase 3 | NCT04458051 | Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) | COMPLETED |